Many new anticancer treatments are molecular targeted agents and only benefit a subgroup of patients within a histologically defined cancer Heterogeneity of treatment effects requires development of ...
Early termination of the 6-minute walk test may be a practical and prognostic marker for severe adverse events in patients with COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback